ClinicalTrials.Veeva

Menu

Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.

Viatris logo

Viatris

Status and phase

Completed
Phase 4

Conditions

Seizures

Treatments

Drug: Pregabalin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00141427
A0081005

Details and patient eligibility

About

To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female subjects with a diagnosis of partial epilepsy.
  • 18 years and older.

Exclusion criteria

  • Having a treatable cause of seizure.
  • Having a progressive neurological or systemic disorder

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

57

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems